25 Feb 2020
Legislation Introduced or Passed in the 116th U.S. Congress
From 17 through 23 February 2020, members of the U.S. Congress introduced and/or approved the following international trade-related bills that may have an impact on Hong Kong or mainland China.
To direct the Secretary of Health and Human Services to study American dependence on unsafe mainland Chinese pharmaceuticals and to empower the Food and Drug Administration to mandate drug recalls in the case of critical contamination
Referred to House Energy and Commerce Committee
To ensure greater transparency about the terms and conditions of financing provided by mainland China to member states of the international financial institutions
Referred to House Financial Services Committee